secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibikase Therapeutics, Inc. (IKT)
CIK:        0001750149
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001193125-25-326916
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inhibikase Therapeutics files prospectus supplement for $185M ATM offering via Jefferies
--------------------------------------------------------------------------------

- Inhibikase may sell up to $185M of common stock under existing ATM program through Jefferies LLC.
- Prospectus supplement filed Dec 19, 2025, under registration statement on Form S-3 (File 333-288213).
- Sales Agreement with Jefferies LLC was originally dated June 20, 2025.
- No specific use of proceeds stated; offering conducted from time to time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750149/000119312525326916/0001193125-25-326916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750149/000119312525326916/d212017d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-326916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer